Wilson Sonsini Goodrich & Rosati advised Cyrano Therapeutics on the transaction.Cyrano Therapeutics, a clinical-stage regenerative medicine company pioneering the development of treatments for smell loss, announced…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
